Jeffrey S. Aronin is the chairman and chief executive officer of Paragon Pharmaceuticals, a global development and biopharmaceutical investment firm that establishes, fosters, and manages life science companies. Aronin recently gave the keynote presentation at the KEC Angel Networking Reception.
Previously, he was founder, president, and CEO of Ovation Pharmaceuticals, a company he started in 2000 and sold in 2009 for $900 million to Danish pharmaceutical manufacturer Lundbeck. In recognition of Aronin’s business leadership, he was awarded Ernst & Young’s 2006 Entrepreneur of the Year among Emerging Companies, named one of Pharmaceutical Executive’s 45 under 45, and recognized in 2005 and 2008 as one of the 100 Most Inspiring People in the life science industry by readers of PharmaVOICE magazine.
Popular Bookmarks
More Bookmarks
Share this Video
About The Author
antoinette is
Email this author | All posts by antoinette
Loading...

RSS feed for comments on this post. • TrackBack URL
Leave a Reply